Morales-Vázquez María Margarita, Meza-Serrano Europa, Lara-Pereyra Irlando, Acuña-González Ricardo Josué, Alonso-Morales Rogelio, Hayen-Valles Sergio, Boeta Ana Myriam, Zarco Luis, Lozano-Cuenca Jair, López-Canales Jorge Skiold, Flores-Herrera Héctor
Departamento de Immunobioquímica, Instituto Nacional de Perinatología "Isidro Espinosa de los Reyes" INPerIER, Ciudad de México 11000, CP, Mexico.
Departamento de Reproducción, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México 04510, CP, Mexico.
Vet Sci. 2023 Aug 22;10(9):532. doi: 10.3390/vetsci10090532.
Equine placentitis is characterized by infection and inflammation of the placenta. Different biomarkers associated with this inflammatory response have been evaluated in experimentally induced equine placentitis, but not in pregnant mares with spontaneous placentitis. The aim of the current study was to determine the concentration of IL-1β and the activity of MMP-2 and MMP-9 in the serum of healthy mares and mares with placentitis on days 240 and 320 of gestation to explore whether these biomarkers are associated with equine maternal placentitis and/or with the birth of an infected or inviable foals. Serum samples were collected from sixteen pregnant English Thoroughbred mares, retrospectively classified as follows: (1) healthy mares with full-term gestation; and (2) mares with ultrasonographic signs of placentitis. The health of each foal was examined at birth, and it was decided to classify the cases into four groups: (1) healthy mares delivering a healthy foals (HM-HF, = 6); (2) mares with USP delivering a healthy foal (USP-HF, = 3); (3) mares with USP delivering a live septic foal (USP-LSeF, = 4); and (4) mares with USP delivering a dead foal (USP-DF, = 3). IL-1β was quantified by ELISA, and MMP-2 and MMP-9 activity by gelatin zymography electrophoresis. In healthy mares, the serum concentrations of IL-1β underwent a significant 16.5-fold increase from day 240 to day 320 of gestation. Although similar results were found in the mares with ultrasonographic signs of placentitis that delivered a healthy foal, those delivering a live septic or nonviable foal exhibited much higher concentrations of eIL-1β. MMP-2 and MMP-9 activity was not associated with maternal placentitis, foal infection, or death. Hence, the presence of placentitis severe enough to affect the health of the foal can be confirmed or discarded by determining the IL-1β concentration in mares that have shown ultrasonographic signs of placentitis.
马胎盘炎的特征是胎盘感染和炎症。在实验诱导的马胎盘炎中已对与这种炎症反应相关的不同生物标志物进行了评估,但在患有自发性胎盘炎的怀孕母马中尚未进行评估。本研究的目的是确定妊娠第240天和第320天时健康母马和患有胎盘炎的母马血清中IL-1β的浓度以及MMP-2和MMP-9的活性,以探讨这些生物标志物是否与马母体胎盘炎和/或感染或无法存活的马驹的出生有关。从16匹怀孕的英国纯种母马中采集血清样本,回顾性分类如下:(1)足月妊娠的健康母马;(2)有胎盘炎超声征象的母马。在出生时检查每匹马驹的健康状况,并决定将病例分为四组:(1)分娩健康马驹的健康母马(HM-HF,n = 6);(2)有超声胎盘炎征象的母马分娩健康马驹(USP-HF,n = 3);(3)有超声胎盘炎征象的母马分娩存活的败血症马驹(USP-LSeF,n = 4);(4)有超声胎盘炎征象的母马分娩死胎(USP-DF,n = 3)。通过ELISA定量IL-1β,通过明胶酶谱电泳定量MMP-2和MMP-9活性。在健康母马中,妊娠第240天至第320天血清IL-1β浓度显著增加了16.5倍。虽然在分娩健康马驹且有胎盘炎超声征象的母马中发现了类似结果,但分娩存活的败血症或无法存活马驹的母马表现出更高的eIL-1β浓度。MMP-2和MMP-9活性与母体胎盘炎、马驹感染或死亡无关。因此,通过测定有胎盘炎超声征象的母马中IL-1β的浓度,可以确认或排除足以影响马驹健康的严重胎盘炎的存在。